Table 2 |
||||||
|
Pharmacotechnical characteristics of ASAQ alcoholic/aqueous granulation tablet formulations with or without binder* |
||||||
|
Batch n° |
11128G |
11213(1) |
11129 |
11128P |
11124 |
11130 |
|
|
||||||
|
Tablet dosage AS/AQ (mg/mg) |
100/270 |
100/270 |
100/270 |
25/67,5 |
25/67,5 |
25/67,5 |
|
|
||||||
|
Granulation |
Aqueous + PVP* |
Alcoholic + PVP* |
Alcoholic without PVP* |
Aqueous + PVP* |
Alcoholic + PVP* |
Alcoholic without PVP* |
|
|
||||||
|
Mean tablet weight (mg) |
494 |
480 |
476 |
129 |
123 |
120 |
|
|
||||||
|
Hardness (N) |
73 |
65 |
69 |
72 |
60 |
59 |
|
|
||||||
|
Disintegration time (min) |
4 |
< 1 |
< 1 |
5 |
< 3 |
< 3 |
|
|
||||||
|
Friability (%) |
1.25 |
ND |
2.6 |
0.7 |
ND |
1.04 |
|
|
||||||
|
Drugs released after 45 min of dissolution test (AQ%/AS%) |
92/76 |
94/83 |
98/91 |
100/86 |
ND |
100/106 |
|
|
||||||
|
Key: ND = not determined; binder = PVP K30 10% solution |
||||||
|
Lacaze et al. Malaria Journal 2011 10:142 doi:10.1186/1475-2875-10-142 |
||||||